Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2010
03/17/2010EP1095035B1 Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
03/17/2010EP1031569B1 Salt of a 7-isoindolinequinolonecarboxylic acid derivative, monohydrate thereof and composition containing the same as active ingredient
03/17/2010CN101675056A Heterocyclic compounds and their use as pesticides
03/17/2010CN101675040A Pyridine derivatives
03/17/2010CN101675039A acetone solvate of phthaloyl amlodipine
03/17/2010CN101675038A Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
03/17/2010CN101675036A dual-acting benzoimidazole antihypertensive agents
03/17/2010CN101675034A Pyridone derivatives as p38a mapk inhibitors
03/17/2010CN101675032A Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
03/17/2010CN101674836A Novel dosage form
03/17/2010CN101674727A Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
03/17/2010CN101671328A Novel synthesis method of sulfonylurea weedicide
03/17/2010CN101671327A Method for synthesizing nicosulfuron
03/17/2010CN101671326A Microbial treatment technology for extracting nicotine
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101671291A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN101669952A Pyridazine derivatives and their use as therapeutic agents
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678908 Process of preparing desaloratadine
03/16/2010US7678816 Method of stabilizing lansoprazole
03/16/2010US7678814 Aroyl-piperidine derivatives
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678811 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
03/16/2010US7678809 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
03/16/2010US7678805 inhibitors are unable to promote death of IL-3 dependent cells cultured in presence of IL-3; non-toxic, selective and potent
03/16/2010US7678804 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678800 2-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2329881C Compounds with growth hormone releasing properties
03/11/2010WO2010028259A2 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers
03/11/2010WO2010028254A2 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
03/11/2010WO2010027746A2 Hedgehog pathway modulators
03/11/2010WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications
03/11/2010WO2010026212A1 Novel inhibitors
03/11/2010WO2010026134A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
03/11/2010WO2010026124A1 Picolinamide derivatives as kinase inhibitors
03/11/2010WO2010026122A1 Heterocyclic pim-kinase inhibitors
03/11/2010WO2010026121A1 Bicyclic kinase inhibitors
03/11/2010WO2010026096A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
03/11/2010WO2010026095A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010WO2010026075A1 Pyridine derivatives as inhibitors of hiv-i reverse transcriptase
03/11/2010WO2010025890A1 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025831A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010WO2010020432A8 Compounds for treatment of duchenne muscular dystrophy
03/11/2010WO2010011821A3 Dual-acting antihypertensive agents
03/11/2010WO2010007114A3 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2009143507A3 Silent desensitizers of neuronal nachr and methods of use thereof
03/11/2010WO2009109654A3 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
03/11/2010WO2009050734A9 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines
03/11/2010WO2009012275A9 Pyridone gpr119 g protein-coupled receptor agonists
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063293 Process for producing anthranilamide compound
03/11/2010US20100063284 SOLID FORMS OF 1-ethyl-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZOL-2-YL)UREA
03/11/2010US20100063279 Method for producing quinolone carboxylic acid derivative
03/11/2010US20100063278 N-Formyl Hydroxylamines compounds
03/11/2010US20100063107 Hydroxy methyl phenyl pyrazolyl urea compounds usefull in the treatment of cancer
03/11/2010US20100063106 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063103 (3-{[2-(Benzenesulfonyl)pyridin-3-yl]methyl}-5-fluoro-2-methylindol-1-yl)-acetic acid, used in the treatment of allergic or inflammatory diseases mediated by prostaglandin D2 (PGD2) or other agonists acting at the oattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) receptor
03/11/2010US20100063102 Treatment of faecal incontinence
03/11/2010US20100063101 New benzimidazole derivatives
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063097 Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors
03/11/2010US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/11/2010US20100063092 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
03/11/2010US20100063089 Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1h-pyrazol-3-yl)phenoxy)methyl)quinoline
03/11/2010US20100063081 CPCR Agonists
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063069 Gyrase inhibitors and uses thereof
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063066 Raf inhibitor compounds and methods of use thereof
03/11/2010US20100063064 3-(4-Fluoro-2-methyl-phenyl)-6-[5-methoxymethyl-4-(6-methoxy-pyridin-3-yl)-4H-[1,2,4]triazol-3-yl]-pyridazine; treatment of male sexual dysfunction, female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, sexual pain disorder, or premature ejaculation
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063061 Antibacterial quinoline derivatives
03/11/2010US20100063059 Novel pyridazine compound and use thereof
03/11/2010US20100063058 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
03/11/2010US20100063056 Bipyridine carboxamide orexin receptor antagonists
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/2010US20100063040 Sulfonamide Derivative Having PGD2 Receptor Antagonistic Activity
03/11/2010US20100063026 Antibacterial quinoline derivatives
03/11/2010US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010US20100062971 such as 2-{3-[2-(4-Methoxy-phenyl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta -D-glucopyranoside, used for for treating diabetes, Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010US20100062065 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 1080